GLPBio

Atherosclerosis

Products Related to Atherosclerosis(88)

  • GC18241 structure
    GC18241Lysophosphatidylcholines
    CAS: 9008-30-4
    Purity: >99.50%

    Lysophosphatidylcholines constitue une classe importante de molécules de phospholipides, qui est le produit de l'hydrolyse de la phosphatidylcholine par la phospholipase A2.

  • GC18522 structure
    GC18522Phosphatidylserines (sodium salt)
    CAS: 383908-63-2
    Purity: >95.00%

    Phosphatidylserine is a naturally occurring phospholipid that comprises 2-10% of total phospholipids in mammals and is enriched in the central nervous system, particularly the retina.

  • GC18616 structure
    GC18616MMP-8 Inhibitor I
    CAS: 236403-25-1
    Purity: >98.00%

    MMP-8 Inhibitor I est un puissant inhibiteur de la métalloprotéinase matricielle 8 (MMP-8) avec une faible biodisponibilité orale.

  • GC18788 structure
    GC18788Graphislactone A
    CAS: 52179-44-9
    Purity: >98%

    Graphislactone A is an antioxidant produced by Cephalosporium IFB-E001 and M.

  • GC19433 structure
    GC19433Cholesteryl Heptadecanoate
    CAS: 24365-37-5
    Purity: >97.00%

    Cholesteryl heptadecanoate is a cholesterol ester (CE) formed by the condensation of cholesterol with heptadecanoic acid, a C-17 saturated fatty acid that does not occur in any natural animal or vegetable fat at high concentrations.

  • GC19460 structure
    GC194609(S)-HODE
    CAS: 73543-67-6
    Purity: >98.00%

    9(S)-HODE is produced by the lipoxygenation of linoleic acid in both plants and animals.

  • GC20172 structure
    GC20172N-Isopropylphthalimide
    CAS: 304-17-6
    Purity: >98.0%(GC)
  • GC33760 structure
    GC33760ETC-1002 (ESP-55016)
    CAS: 738606-46-7
    Purity: >98.00%

    ETC-1002 (ESP-55016) est un nouvel agent hypolipémiant oral à prise quotidien qui inhibe la critrate lyase adénosine triphosphate (ACL), une enzyme de la voie de synthèse du cholestérol, et entraîne une augmentation de la régulation des récepteurs du cholestérol des lipoprotéines de basse densité (LDL), avec une demi-vie comprise entre 15 et 24 heures.

  • GC40053 structure
    GC400535α,6α-epoxy Cholestanol
    CAS: 1250-95-9
    Purity: >95.00%

    5α,6α-epoxy Cholestanol est un dérivé du cholestérol qui peut être généré par voie de catalyse par le système d'enzyme cytochrome P450 dans les mitochondries ou peut être induit lors de la peroxydation des lipides. 5α,6α-epoxy Cholestanol peut réguler la biosynthèse des acides biliaires et induire la différenciation et la mort des cellules tumorales.

  • GC40142 structure
    GC40142Lactosylceramides (bovine buttermilk)
    CAS: 4682-48-8
    Purity: >98.00%

    Lactosylceramide (LacCer) is an endogenous bioactive sphingolipid.

  • GC40202 structure
    GC402027α-hydroxy Cholesterol-d7
    CAS: 349553-94-2
    Purity: >99.00%

    7α-hydroxy Cholesterol-d7 is intended for use as an internal standard for the quantification of 7α-hydroxy cholesterol by GC- or LC-MS.

  • GC40203 structure
    GC40203Cholesterol-d6
    CAS: 60816-17-3
    Purity: >99.00%

    Cholesterol-d6 is intended for use as an internal standard for the quantification of cholesterol by GC- or LC-MS.

  • GC40418 structure
    GC404185β,6β-epoxy Cholestanol
    CAS: 4025-59-6
    Purity: >95.00%

    5β,6β-epoxy Cholestanol is an oxidative metabolite of cholesterol that is formed via radical and non-radical oxidation of cholesterol at the 5,6-double bond.

  • GC40467 structure
    GC40467(±)11-HETE
    CAS: 73804-65-6
    Purity: >98.00%

    (±)11-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid.

  • GC40624 structure
    GC40624MMP-3 Inhibitor VIII
    CAS: 208663-26-7
    Purity: >95.00%

    Matrix metalloproteinases (MMPs) belong to a family of proteases that play a crucial role in tissue remodeling and repair by degrading extracellular matrix proteins to enable cell migration.

  • GC41614 structure
    GC4161424-dehydro Cholesterol
    CAS: 313-04-2
    Purity: >98.00%

    Le 24-déhydrocholestérol est une molécule similaire au cholestérol.

  • GC41636 structure
    GC41636CAY10487
    CAS: 778624-05-8
    Purity: >98.00%

    The early stage of atherosclerosis is characterized by the aggregation of foam cells, so called a fatty streak, in the inner arterial wall.

  • GC41649 structure
    GC41649(±)13-HODE cholesteryl ester
    CAS: 167354-91-8
    Purity: >98.00%

    (±)13-HODE cholesteryl ester was originally extracted from atherosclerotic lesions and shown to be produced by Cu2+-catalyzed oxidation of LDL.

  • GC41666 structure
    GC41666(±)9-HODE cholesteryl ester
    CAS: 33783-76-5
    Purity: >98.00%

    (±)9-HODE cholesteryl ester was originally extracted from atherosclerotic lesions and shown to be produced by Cu2+-catalyzed oxidation of LDL.

  • GC41893 structure
    GC4189313(R)-HODE cholesteryl ester
    CAS: 330800-94-7
    Purity: >98.00%

    13(R)-HODE cholesteryl ester was originally extracted from atherosclerotic lesions.

  • GC41895 structure
    GC4189513(S)-HODE cholesteryl ester
    CAS: 141554-21-4
    Purity: >98.00%

    13(S)-HODE cholesteryl ester was originally extracted from atherosclerotic lesions.

  • GC41897 structure
    GC4189713(S)-HOTrE
    CAS: 87984-82-5
    Purity: >98.00%

    13(S)-HOTrE is the 15-lipoxygenase (15-LO) product of linolenic acid.

  • GC42411 structure
    GC424114-hydroxy Nonenal Alkyne
    CAS: 1011268-23-7
    Purity: >98.00%

    4-hydroxy Nonenal (4-HNE) is a major aldehyde produced during the lipid peroxidation of ω-6 polyunsaturated fatty acids, such as arachidonic acid and linoleic acid.

  • GC42634 structure
    GC426349(R)-HODE cholesteryl ester
    CAS: 330800-93-6
    Purity: >98.00%

    9(R)-HODE cholesteryl ester was originally extracted from atherosclerotic lesions.